Pfizer has launched the Regenerative Medicine research unit. According to the company, this independent unit will research the biology of stem cells and the opportunity they provide to discover and develop a new generation of regenerative medicines for major medical needs. The unit will explore the use of stem cells to develop treatments that may prevent disability, repair failing organs and treat degenerative diseases with the goal of delivering new medicinal products using cells as therapeutic...